Skip to main content
SpringerLink
Log in

FDA promotes campaign against substandard, counterfeit meds

  • Review
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. US FDA. FDA Commissioner Margaret A. Hamburg's Statement on the Institute of Medicine's Report "Countering the Problem of Falsified and Substandard Drugs". Media Release : 13 Feb 2013. Available from: URL: http://www.fda.gov.

  2. Institute of Medicine of the National Academies. Countering the Problem of Falsified and Substandard Drugs - Report Brief. Internet Document : [4 pages], 1 Feb 2013. Available from: URL: http://www.iom.edu.

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

FDA promotes campaign against substandard, counterfeit meds. Reactions Weekly 1441, 4 (2013). https://doi.org/10.1007/s40278-013-1605-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-013-1605-4

Search

Navigation